Grants > Effect of ECM Ligands on RPE Attachment to Bruch's
Updated On: Jun 16, 2026
Macular Degeneration Research Grant
Effect of ECM Ligands on RPE Attachment to Bruch's
Innovative Approaches to Macular Degeneration Treatments
About the Research Project
Program
Macular Degeneration Research
Award Type
Standard
Award Amount
$50,000
Active Dates
April 01, 1999 - March 31, 2000
Grant ID
M1999018
Goals
Grantee institution at the time of this grant: University of Medicine and Dentistry of New Jersey
Related Grants
Macular Degeneration Research
Development of an Oral Treatment for Dry AMD Using Everyday Anti-Inflammatory Drugs
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Marco Bassetto, PhD
Current Organization
University of California, Irvine
Development of an Oral Treatment for Dry AMD Using Everyday Anti-Inflammatory Drugs
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Marco Bassetto, PhD
Current Organization
University of California, Irvine
Macular Degeneration Research
Targeted Removal of Disease-Causing Protein in Age-Related Macular Degeneration
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Celia Bisbach, PhD
Current Organization
University of Wisconsin-Madison
Targeted Removal of Disease-Causing Protein in Age-Related Macular Degeneration
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Celia Bisbach, PhD
Current Organization
University of Wisconsin-Madison
Macular Degeneration Research
A Novel Implantable Device to Treat Wet Macular Degeneration
Active Dates
July 01, 2025 - June 30, 2028
Principal Investigator
Charles DeBoer, MD, PhD
Current Organization
Stanford University
A Novel Implantable Device to Treat Wet Macular Degeneration
Active Dates
July 01, 2025 - June 30, 2028
Principal Investigator
Charles DeBoer, MD, PhD
Current Organization
Stanford University